Industry Sponsored Session
09-11, 13:00–14:00 (Europe/Istanbul), Head & Neck 1 (ICC - B2 Floor - Üsküdar 2)

Objectives:

1. Describe the unmet medical needs in locally advanced head and neck squamous cell carcinoma (LA HNSCC),

2. Explain the scientific and clinical rationale for the use of immuno-oncology therapies in the neoadjuvant and adjuvant settings for resectable LA HNSCC,

3. Review and interpret the most recent clinical data in resectable LA HNSCC,

4. Apply emerging evidence and evolving standards to optimize patient care in the new era of resectable LA HNSCC, with a focus on individualized treatment planning, multidisciplinary collaboration, and improving patient outcomes

Speaker Speaker
Christian Simon
Welcome and Introduction
Christian Simon
(13:00 - 13:05)
IO rationale: Resectable LA HNSCC
(13:05 - 13:10)
Recent updates: Resectable LA HNSCC
(13:10 - 13:25)
Patient Case Studies: Resectable LA HNSCC
(13:25 - 13:40)
Q&A
(13:40 - 13:50)
Closing Remarks
Christian Simon
(13:50 - 13:55)
Christian Simon
This speaker also appears in: